<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D6BBD01A-3F5B-493C-847A-6B0CD71AA220"><gtr:id>D6BBD01A-3F5B-493C-847A-6B0CD71AA220</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:surname>Medvinsky</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500950"><gtr:id>41E965AF-5C98-4935-89F9-FF43D2582B5C</gtr:id><gtr:title>Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500950</gtr:grantReference><gtr:abstractText>The main focus of this research proposal is in the development and regulation of blood stem cells by a gene called AML1/Runx1. Stem cells are one of the main foci of current biology due to their potential to self-replicate and give rise to a variety of mature cells. AML1/Runx1 is critically important for the development of the adult blood system and is frequently involved in the development of human leukaemias. AML1/Runx1 gene produces different forms of the protein which can compete for the influence on other genes which are involved in stem cell development and function as well in the development of leukaemias. We have generated genetically altered embryonic stem (ES) cells and mouse experimental systems which allow AML1/Runx1 gene to be artificially regulated. Regulation of AML1/Runx1 gene is achieved by the use of a modern bi-component tetracycline inducible system. The design of the system enables fine tuning of levels of the AML1/Runx1 protein in cells. The influence of these AML1/Runx1 proteins will be studied in cultured ES cells as well as in developing mouse embryos and in the adult mouse. Two additional genetically modified mice which have fluorescent tagged genes controlled by AML1/Runx1 will also be used in this research to enable accurate identification of cells which express AML1 protein. Better understanding of stem cell regulation and the role of AML1 in this process will have potential implications for the development of protocols for practical regenerative medicine.</gtr:abstractText><gtr:technicalSummary>The Runx1/AML1 is critically important for development of the definitive haematopoietic system and is one of the most frequent targets in chromosome rearrangements associated with leukaemias. Runx1/AML1 gene encodes for a RUNT homology domain transcription factor which functions as a heteromeric transcription factor complex (AML1:CBFb). Normal haematopoietic development and some forms of leukaemia are AML1 dose dependent. AML1 locus generates a number of splice isoforms which may play different specific roles in cell differentiation. The short isoform of AML1 lacking transcription activation domain is of particular interest since it can be a dominant negative regulator of long AML1 isoforms. Due to this and co-operation with different co-factors AML1 exerts complex regulatory effects on cells which are poorly understood. 
In this research proposal the influence of AML1/Runx1 isoforms and their expression levels on the generation and the condition of stem/progenitor cells will be analysed in i) an embryonic stem (ES) cell differentiation system, ii) in embryonic development and in iii) the adult organism. Tetracycline-inducible ES cell and mouse systems generated in the lab will be used for this purpose. The design of these systems allows inducibility and expression levels of AML1 to be monitored. The analysis will be complemented by the use of AML1-YFP non-invasive knock-in reporter mice which will allow identification of AML1-expressing cells in vivo. Furthemore, HoxB4-YFP knock-in reporter mice will be used to monitor the condition of ?stemness? of HSCs upon overexpression of AML1 isoforms.
The proposed research will use methods of in vitro haematopoietic and endothelial differentiation. The influence of AML1 isoforms on haemangioblast and haemogenic endothelium will be investigated in culture and supported by extensive flow cytometry analysis and long-term transplantation studies.</gtr:technicalSummary><gtr:fund><gtr:end>2009-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>468117</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Teaching (European Stem Cell School and in University of Edinburgh)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>E95D2717-F249-4C13-9CAE-C67642ED70F7</gtr:id><gtr:impact>Students have much better idea about the process of haematopoietic stem cell development</gtr:impact><gtr:outcomeId>8009D8EF51E</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A multifunctional reversible knockout/ reporter system enabling fully functional reconstitution of the AML1/Runx1 locus and rescue of haematopoiesis</gtr:description><gtr:id>C2FFB445-7359-4C17-9699-18CD67871041</gtr:id><gtr:impact>Analysis of these mice was an important tool used in publication: N. Stifaniet al(2008) &amp;quot;Suppression of interneuron programs and maintenance of selected spinal motor neuron fates by the transcription factor AML1/Runx1. Proc Natl Acad Sci USA 105, No 17, 6451-6456</gtr:impact><gtr:outcomeId>580CBB24DEF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Runx1 reversible knockout/ reporter mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a culture system of embryonic AGM region cells which after reaggregation resume generation of the HSC development. This enables analysis of of individual cell populations in HSC development to be performed.</gtr:description><gtr:id>5486B74D-8BC2-4ED9-9462-D60B0E20A63E</gtr:id><gtr:impact>Elucidating the mechanisms underlying HSC specification and expansion in the embryo have been hampered by the lack of analytical cell culture systems that recapitulate in vivo development. We developed a novel ex vivo model that facilitates a rapid and robust emergence of multipotent long-term repopulating HSCs in the embryonic AGM region and enables analysis of individual cell populations involved in this process to be performed. Using this model, we established the identity of pre-HSCs which mature into definitive HSCs. The importance of this study is dual i) it will shed light on one of the central problems of HSC biology, namely, genetic regulation of early HSC development and ii) provide mechanistic data for potential development of clinically relevant protocols aiming to enhance production of haematopoietic progenitors and stem cells in vitro.</gtr:impact><gtr:outcomeId>F924FB1EFC0</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Novel ex vivo HSC generation system</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>These transgenic mice allow upregulation of short and long Runx1 isoforms in mice</gtr:description><gtr:id>42260C1B-9CB2-46DC-AF02-EFB94F3915F0</gtr:id><gtr:impact>THese mice were analysed by our collaborators which resulted in publication: Aldskogius, et al . &amp;quot;Regulation of Boundary Cap Neural Crest Stem Cell Differentiation after Transplantation&amp;quot; Stem Cells 27, 1592- 1603</gtr:impact><gtr:outcomeId>BA51BE037BC</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Tetracycline-inducible Runx1 (short and long isoform) transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>18033618-8FD8-4BD7-9B2E-7558CE46988A</gtr:id><gtr:title>Embryonic origin of the adult hematopoietic system: advances and questions.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2d7c248b866529230b7bb8337d949fb"><gtr:id>a2d7c248b866529230b7bb8337d949fb</gtr:id><gtr:otherNames>Medvinsky A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>Bu4ozrWiByX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA084710-E629-4B32-9986-A62A6709ECF0</gtr:id><gtr:title>Suppression of interneuron programs and maintenance of selected spinal motor neuron fates by the transcription factor AML1/Runx1.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/174074611c326542122641acee9248cd"><gtr:id>174074611c326542122641acee9248cd</gtr:id><gtr:otherNames>Stifani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>911946A6D03</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>198A6131-6D9D-4C0A-BF25-953E0C065957</gtr:id><gtr:title>The essential requirement for Runx1 in the development of the sternum.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35dccae258e23c88a8f3f1354099c84"><gtr:id>f35dccae258e23c88a8f3f1354099c84</gtr:id><gtr:otherNames>Liakhovitskaia A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>jRQpoWvrSkd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C0D508B-821E-4907-9AA0-0D6ED2DE17C2</gtr:id><gtr:title>Regulation of boundary cap neural crest stem cell differentiation after transplantation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff54cf7c528e7dca1c19949b6bd229f2"><gtr:id>ff54cf7c528e7dca1c19949b6bd229f2</gtr:id><gtr:otherNames>Aldskogius H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>76160493BB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA8019F7-A332-47AE-9C4F-22227BAFCFFF</gtr:id><gtr:title>Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebf73686c860f2bfdb481b74a36f2b68"><gtr:id>ebf73686c860f2bfdb481b74a36f2b68</gtr:id><gtr:otherNames>Taoudi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>DE46861B084</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>129015FE-8450-4A86-BA72-4A438ED6FA92</gtr:id><gtr:title>Tracing the origin of the HSC hierarchy reveals an SCF-dependent, IL-3-independent CD43(-) embryonic precursor.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c957b8c02a7d0f58b62a45d6956dfcc5"><gtr:id>c957b8c02a7d0f58b62a45d6956dfcc5</gtr:id><gtr:otherNames>Rybtsov S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>54649a8faa5220.48275139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C5EE46F-67A1-4207-ACE2-499B9E6DA86B</gtr:id><gtr:title>Signaling from the sympathetic nervous system regulates hematopoietic stem cell emergence during embryogenesis.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70201fa9a5d115e824451e37e2e00093"><gtr:id>70201fa9a5d115e824451e37e2e00093</gtr:id><gtr:otherNames>Fitch SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_16325_25_23040481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>378654F6-8B3B-45B8-A61C-BA6D879AD402</gtr:id><gtr:title>Runx1 is required for progression of CD41+ embryonic precursors into HSCs but not prior to this.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35dccae258e23c88a8f3f1354099c84"><gtr:id>f35dccae258e23c88a8f3f1354099c84</gtr:id><gtr:otherNames>Liakhovitskaia A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>54649a8f843874.38009209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB61D623-2020-4DA1-BA9B-407728B72F7B</gtr:id><gtr:title>Restoration of Runx1 expression in the Tie2 cell compartment rescues definitive hematopoietic stem cells and extends life of Runx1 knockout animals until birth.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35dccae258e23c88a8f3f1354099c84"><gtr:id>f35dccae258e23c88a8f3f1354099c84</gtr:id><gtr:otherNames>Liakhovitskaia A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>457C8497678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2103AB9A-F1CC-46CE-B25C-56B4D217C116</gtr:id><gtr:title>A lineage of diploid platelet-forming cells precedes polyploid megakaryocyte formation in the mouse embryo.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe4df178fc4625819527d34b6dbf33c9"><gtr:id>fe4df178fc4625819527d34b6dbf33c9</gtr:id><gtr:otherNames>Potts KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>54649a8f5a9513.16622353</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDABC567-C630-4BAC-8AFC-A3D15423F65D</gtr:id><gtr:title>Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c957b8c02a7d0f58b62a45d6956dfcc5"><gtr:id>c957b8c02a7d0f58b62a45d6956dfcc5</gtr:id><gtr:otherNames>Rybtsov S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_5435aa55aa53372bf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EE3DFF1-1A95-4C56-8F3E-5185EE993BCF</gtr:id><gtr:title>Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc654702d436dfd3db33f8d85993cd87"><gtr:id>dc654702d436dfd3db33f8d85993cd87</gtr:id><gtr:otherNames>Voronov D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_16325_25_23532528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E4A75B5-99C7-4C68-A5E6-E5191D0757D0</gtr:id><gtr:title>The discovery of a source of adult hematopoietic cells in the embryo.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/021b0c585bc8af00d38dc95109a583f5"><gtr:id>021b0c585bc8af00d38dc95109a583f5</gtr:id><gtr:otherNames>Dzierzak E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>52D26DC12FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89039566-22E0-41FA-A9C5-20AC1DCF4A8E</gtr:id><gtr:title>Developing HSCs become Notch independent by the end of maturation in the AGM region.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff4e0e893877b2667f158997d3fef8e7"><gtr:id>ff4e0e893877b2667f158997d3fef8e7</gtr:id><gtr:otherNames>Souilhol C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5a94306f6490e7.31007110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1E951F2-6F40-4324-B4CF-E9B203457537</gtr:id><gtr:title>Alternative Runx1 promoter usage in mouse developmental hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Blood cells, molecules &amp; diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a20cee98cf9ca5d8383c0218c256d107"><gtr:id>a20cee98cf9ca5d8383c0218c256d107</gtr:id><gtr:otherNames>Bee T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1079-9796</gtr:issn><gtr:outcomeId>652F9668D20</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B84A71AB-38D5-4694-8B16-5B365C93D1FF</gtr:id><gtr:title>Multifunctional reversible knockout/reporter system enabling fully functional reconstitution of the AML1/Runx1 locus and rescue of hematopoiesis.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaf90f663a82d7f5b7e2626e4de006c8"><gtr:id>eaf90f663a82d7f5b7e2626e4de006c8</gtr:id><gtr:otherNames>Samokhvalov IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn><gtr:outcomeId>E46DC8E3629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06D2A239-F588-4A4E-846A-7CA0F9A3B131</gtr:id><gtr:title>Analysis and manipulation of hematopoietic progenitor and stem cells from murine embryonic tissues.</gtr:title><gtr:parentPublicationTitle>Current protocols in stem cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2d7c248b866529230b7bb8337d949fb"><gtr:id>a2d7c248b866529230b7bb8337d949fb</gtr:id><gtr:otherNames>Medvinsky A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1938-8969</gtr:issn><gtr:outcomeId>8E4C0844C73</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500950</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>